Overview

Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung Disease

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether sildenafil can decrease inflammation in CF lung disease.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
National Jewish Health
Collaborators:
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation Therapeutics
Treatments:
Phosphodiesterase Inhibitors
Sildenafil Citrate